Ultrasound Microvessel Imaging for Patient-Derived Xenografts to Direct Decision Making in the Multi-Line Setting for Advanced HCC and Metastatic RCC Patients | Medical Biophysics Poster Day
less than 1 minute read
The CAM PDX model, a novel patient xenograft tumour model developed by engrafting and growing diagnostic biopsy samples in avian chorioallantoic membranes (CAMs), could be used to evaluate the effectiveness of therapeutics with the objective of personalizing treatment.
In this preliminary work, we present an overview of the PDX model and investigate its sensitivity to the effects of Sunitinib, a tyrosine kinase inhibitor, on renal cell carcinoma (RENCA).
Please find the poster here.